echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Plos Med: Vaccination can reduce the risk of yellow fever outbreak by 86%

    Plos Med: Vaccination can reduce the risk of yellow fever outbreak by 86%

    • Last Update: 2021-03-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In recent years, there has been another outbreak of yellow fever in Africa and Latin America.


    In recent years, there has been another outbreak of yellow fever in Africa and Latin America.


    At present, in response to various large-scale vaccination campaigns ( PMVC ) for yellow fever vaccination , few studies have quantified the impact of PMVC on the risk of yellow fever outbreaks.


    In this study, the researchers assessed the association between yellow fever outbreaks in endemic areas in Africa and the implementation of PMVCs through self-controlled case series ( SCCS ) methods .


    In this study, the researchers used the Self Controlled Case Series (SCCS ) method to evaluate yellow fever outbreaks in endemic areas in Africa, yellow fever outbreaks in endemic areas in Africa , and yellow fever in endemic areas in Africa.


    Researchers assessed the association between provincial PMVC and yellow fever outbreak risk in 34 African countries between 2005 and 2018 .


    Based on the results of SCCS , the researchers estimated that after PMVCs , the number of outbreaks in Africa from 2005 to 2018 decreased by 34% ( 95% CI 22% to 45% ).


    Based SCCS result, researchers estimate PMVCs after 2005 Nian Zhi 2018 for African outbreak reduce the number of 34% PMVCs after 2005 Nian Zhi 2018 for African outbreak reduce the number of 34% PMVCs after 2005 Nian Zhi 2018 for African number of outbreaks A reduction of 34% ( 95% CI 22% to 45% ).


    In summary, these results results results PMVCs yellow fever outbreak has high preventive effect, and SCCS research method can be advantageously applied to different levels of the population, in order to assess the impact of public health interventions.


    Original source

    Kévin Jean et al.


    Kévin Jean et al.
    plos.
    org/plosmedicine/article?id=10.
    1371/journal.
    pmed.
    1003523#sec015" target="_blank" rel="noopener">Assessing the impact of preventive mass vaccination campaigns on yellow fever outbreaks in Africa: A population-level self-controlled case series study .
    Plos Med.
    2021 plos.
    org/plosmedicine/article?id=10.
    1371/journal.
    pmed.
    1003523#sec015" target="_blank" rel="noopener">Assessing the impact of preventive mass vaccination campaigns on yellow fever outbreaks in Africa: A population-level self-controlled case series study org/10.
    1371/journal.
    pmed.
    1003523">https://doi.
    org/10.
    1371/journal.
    pmed.
    1003523org/10.
    1371/journal.
    pmed.
    1003523"> https://doi.
    org/10.
    1371/journal.
    pmed.
    1003523 https://doi.
    org/10.
    1371/ journal.
    pmed.
    1003523 leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.